HTG Announces One-for-Twelve Reverse Stock Split
TUCSON, Ariz. , Dec. 20, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced that as a result of its
- Category:
- Press Releases